Mojgan M Lefebvre, EVP and Chief Technology and Operations Officer of Travelers Companies, Inc., filed a Form 4 on October 28, 2026, disclosing the exercise of stock options and the same-day sale of 11,000 shares of common stock on October 27, 2026.

Key Highlights

  • Option exercise: Lefebvre acquired 11,000 shares of common stock via transaction code M at an exercise price of $139.83 per share on October 27, 2026.
  • Share sale: All 11,000 acquired shares were disposed of on the same date at a weighted average price of $393.844 per share, with individual sales ranging from $393.75 to $394.23.
  • Resulting ownership: Following both transactions, Lefebvre held 0 shares of common stock directly.
  • Remaining options: 10,214 stock options (right to buy) remain beneficially owned directly, with an exercise price of $139.83 and an expiration date of February 2, 2031.
  • Option details: The exercised options became exercisable on February 2, 2024, and were originally set to expire February 2, 2031.
  • Issuer: Travelers Companies, Inc., traded on NYSE:TRV.

Lefebvre's October 2026 Option Exercise and Share Disposition at Travelers

According to the filing, Mojgan M Lefebvre, identified as EVP and Chief Technology and Operations Officer of Travelers Companies, Inc. (NYSE:TRV), reported two linked transactions on October 27, 2026. First, she exercised stock options covering 11,000 shares of common stock at the option exercise price of $139.83 per share, recorded under transaction code M. Immediately following the exercise, she disposed of all 11,000 shares under transaction code S.

The filing disclosed that the 11,000 shares were sold at a weighted average price of $393.844. According to footnote 1, this figure represents the weighted average across price increments ranging from $393.75 to $394.23, and the filing notes that Lefebvre "undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price." Following both transactions, Lefebvre's direct beneficial ownership of common stock stood at 0 shares.

In Table II, the filing reported that 10,214 stock options (right to buy common stock) remain directly held by Lefebvre after the reported transactions. These options carry the same exercise price of $139.83, became exercisable on February 2, 2024, and are set to expire on February 2, 2031. The price of the derivative security for the exercised portion was listed as $0. The form was signed by Wendy C. Skjerven by power of attorney and dated October 28, 2026.

What Was Disclosed

The filing reported the exercise of 11,000 stock options at $139.83 per share and the same-day sale of all resulting common shares at a weighted average of $393.844, leaving Lefebvre with 0 direct common shares and 10,214 remaining stock options as of October 27, 2026.